Nytt ebolautbrudd i DR Kongo – Norge sender spesialister

Det har vært et nytt ebolautbrudd i Den demokratiske republikken Kongo. Regjeringen har besluttet å bidra med 10 millioner kroner til den humanitære responsen på dette utbruddet. Også ved det forrige utbruddet i mai 2018 bidro regjeringen med 10 millioner kroner. Pengene ble blant annet brukt til isolasjonsenheter (bårer) for […]


Perioperative interventions in pelvic organ prolapse surgery

A wide variety of interventions are undertaken at prolapse surgeries; however data are lacking and consensus has not been reached on the efficacy of these interventions. The most reliable evidence is likely to come from randomised controlled trials, and this is the basis for this review. Review questions • Which […]


Cooling plus inhaled xenon for newborns with hypoxic-ischaemic encephalopathy

Authors’ conclusions:  Current evidence from one small randomised controlled pilot trial is inadequate to show whether cooling plus xenon is safe or effective in near-term and term newborns with HIE. Further trials reporting long-term neurodevelopmental outcomes are needed. Read the full abstract… Data collection and analysis:  Two review authors independently […]


CDC Releases 2018 Breastfeeding Report Card

Press Release For Immediate Release: Monday, August 20, 2018Contact: Media Relations(404) 639-3286 Of the approximately 4 million babies born in 2015,  most (83.2 percent) started out breastfeeding – but many stop earlier than recommended, according to the 2018 Breastfeeding Report Card released today by the Centers for Disease Control and Prevention […]


Ökad biverkningsrapportering av intrauterina preventivmedel med gestagen

Totalt rapporterades det in 7 695 biverkningsrapporter till Läkemedelsverket 2017, varav 29 procent kom från konsumenterna. Fortfarande var det flest rapporter från hälso- och sjukvården för blodförtunnande läkemedel, där apixaban (128 st) och warfarin (109 st) var vanligast. Rivaroxaban (78 st) kom på fjärde plats. Hjärnblödning var en vanlig orsak. […]


Des personnalités flamandes s’engagent pour la mer

20/08/2018 Ces dernières semaines, plusieurs visages flamands connus ont à nouveau donné leur meilleure astuce pour protéger la mer du Nord, dans l’émission « Plage Préférée » de Kim Debrie sur Radio 2. Voici les vidéos de Wim Lybaert et Eric Goens, réalisateurs télé, ainsi que du musicien Tom Helsen, lors de cette […]


Forebyggelse og behandling af adfærdsforstyrrelser hos personer med demens

Oprettet 20. august 2018 Sundhedsstyrelsen sender i dag en ny national klinisk retningslinje for forebyggelse og behandling af adfærdsforstyrrelser hos personer med demens i høring. Op mod 90 % af alle mennesker med demens bliver på et tidspunkt i løbet af deres sygdomsforløb ramt af både psykiske og adfærdsmæssige symptomer. […]


Rapporter de l’ivoire au SPF toujours possible

20/08/2018 Suite à la fin de la campagne « Sors tes dents » le 12 août, de l’ivoire a encore déposé dans les containers mis en place au SPF Santé publique, à Pairi Daiza, aux Zoos d’Anvers et à Planckendael. Ainsi, depuis le début de la campagne lancée le 15 mai, c’est […]


News and press releases: Update on medicines containing valsartan from Zhejiang Tianyu

20/08/2018 Update on medicines containing valsartan from Zhejiang Tianyu Company no longer authorised to manufacture valsartan active substance for EU medicines due to presence of NDMA The company Zhejiang Tianyu is no longer authorised to manufacture the valsartan active substance for EU medicines following the suspension of its CEP – […]


No er det klart for lusesjekk

Hovudlus er eit tilbakevendande problem i skolar og barnehagar landet over. Anslagsvis har ein til to prosent av barn i Noreg til ei kvar tid lus. Jamleg lusesjekk reduserer risiko for smitte Skolar og barnehagar kan informere foreldre og føresette om korleis ein sjekkar for og behandlar hovudlus. Folkehelseinstituttet har […]


Ledig bevilling til Hurup Apotek

20. august 2018 Bevillingen til at drive Hurup Apotek er ledig pr. 1. maj 2019.  Bevillingen er opslået ledig efter Lov om apoteksvirksomhed § 15, stk. 1 og stk. 2. Hurup Apotek er beliggende i postnummer 7760. OBS! Vejledning i ansøgning om ledige apoteksbevilliger er d. 13 august 2018 ændret […]


FDA approves Bristol Myers Squibb's Opdivo in small-cell lung cancer

Image Credit: Bristol-Myers Squibb The FDA has approved Bristol Myers Squibb’s Opdivo (nivolumab) for patients with metastatic small-cell lung cancer (SCLC), as the first and only Immuno-Oncology treatment option for whose disease has progressed after platinum-based chemotherapy and at least one other line of therapy. The approval was granted on […]


Regeneron's Eylea wins FDA approval for wet age-related macular degeneration

Regeneron is celebrating the approval in the US of its vascular endothelial growth factor (VEGF) inhibitor Eylea (aflibercept) for the treatment of wet age-related macular degeneration (AMD). The decision was based on second-year Phase 3 data from two trials, demonstrating the efficacy of Eylea in treating wet AMD with a […]


MD Anderson Spins Out Neurosciences Company From Discovery Division

Bio-IT World News Brief | The University of Texas MD Anderson Cancer Center and Accelerator Life Science Partners, a leading life science investment and management firm, have announced the launch of Magnolia Neurosciences Corporation, a company developing a new class of neuroprotective medicines, with $31 million in Series A funding.       […]


Thyroid medication recalled after Chinese supplier fails inspection

The Mississippi based manufacturer Westminster Pharmaceuticals is voluntarily recalling thyroid medications Levothyroxine and Liothyronine after the Chinese company Sichuan Friendly Pharmaceutical Co failed an FDA inspection. Sichuan Pharmaceutical who supplied Westminster with an Active Pharmaceutical Ingredient (API) used in the production of certain thyroid medications were found to have deficiencies […]


More children suffering from type 2 diabetes in England and Wales

The number of children and young people suffering from type-2 diabetes has increased in England in Wales over the past four years, according to figures released by the Royal College of Paediatrics and Child Health (RCPCH). The number of people under the age of 25 being treated for type-2 diabetes […]


Chinese regulators approve Roche's Alecensa in regulatory shift

China’s National Drug Administration has granted rapid approval for Roche’s lung cancer treatment Alecensa (alectinib). Chinese regulators have in the past approved drugs years later than other regions such as Europe and the United States. However the lengthy regulatory process and the associated lack of access to drugs has turned […]